Detalhe da pesquisa
1.
Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation.
Ann Hematol
; 2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38472362
2.
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2.
J Thromb Thrombolysis
; 2024 May 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38762713
3.
Prognostic factors in patients with bone marrow hemophagocytosis and its association with hematologic malignancies.
Hematol Oncol
; 41(1): 167-177, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36305496
4.
Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients.
Transfus Med Hemother
; 50(1): 39-50, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36818774
5.
Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.
J Thromb Thrombolysis
; 53(1): 182-190, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34228248
6.
Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry.
J Thromb Thrombolysis
; 53(2): 540-549, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34524599
7.
Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma.
Support Care Cancer
; 29(7): 3991-3999, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33398428
8.
Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdays.
J Thromb Thrombolysis
; 51(3): 779-788, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32728908
9.
Risk and impact of invasive fungal infections in patients with multiple myeloma.
Ann Hematol
; 99(8): 1813-1822, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32607596
10.
Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolismã- From the COMMAND VTE Registry.
Circ J
; 84(11): 2006-2014, 2020 10 23.
Artigo
Inglês
| MEDLINE | ID: mdl-33012736
11.
D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: from the COMMAND VTE Registry.
J Thromb Thrombolysis
; 49(4): 551-561, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-31571121
12.
Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolismã- From the COMMAND VTE Registry.
Circ J
; 83(7): 1581-1589, 2019 06 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31142685
13.
Clinical Characteristics and Outcomes of Venous Thromboembolisms According to an Out-of-Hospital vs. In-Hospital Onsetã- From the COMMAND VTE Registry.
Circ J
; 83(6): 1377-1384, 2019 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-30930347
14.
Cancer-Associated Venous Thromboembolism in the Real Worldã- From the COMMAND VTE Registry.
Circ J
; 83(11): 2271-2281, 2019 10 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31548438
15.
Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry.
J Thromb Thrombolysis
; 48(4): 587-595, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31278648
16.
Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry.
J Thromb Thrombolysis
; 47(3): 444-453, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30673941
17.
Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry.
Heart Vessels
; 34(4): 669-677, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30293163
18.
Anticoagulation Therapy for Venous Thromboembolism in the Real Worldã- From the COMMAND VTE Registry.
Circ J
; 82(5): 1262-1270, 2018 04 25.
Artigo
Inglês
| MEDLINE | ID: mdl-29576597
19.
Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection.
Hematol Oncol
; 35(4): 835-844, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27465587
20.
No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation.
Blood Cells Mol Dis
; 55(1): 36-9, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25976465